Eisai Ltd ADR (ESALY)

$61.51 0.00 (0.00%)
15:59 EST ESALY Stock Quote Delayed 30 Minutes

Biotech Stocks LLY, ESALY Gain on Biogen’s Positive Trial Results

By Josh Enomoto, InvestorPlace Contributor
Biogen produced an outstanding Phase 3 result for its Alzheimer’s treatment, sending associated biotech stocks soaring.
Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.)
Day's Range -
52-Week Range $60.40 - $73.90
Dividend & Yield N/A (N/A)